ZA200800153B - Inhibitors of soluble adenylate cyclase - Google Patents
Inhibitors of soluble adenylate cyclaseInfo
- Publication number
- ZA200800153B ZA200800153B ZA200800153A ZA200800153A ZA200800153B ZA 200800153 B ZA200800153 B ZA 200800153B ZA 200800153 A ZA200800153 A ZA 200800153A ZA 200800153 A ZA200800153 A ZA 200800153A ZA 200800153 B ZA200800153 B ZA 200800153B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- adenylate cyclase
- soluble adenylate
- soluble
- cyclase
- Prior art date
Links
- 102000030621 adenylate cyclase Human genes 0.000 title 1
- 108060000200 adenylate cyclase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005027274A DE102005027274A1 (de) | 2005-06-08 | 2005-06-08 | Inhibitoren der löslichen Adenylatzyklase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200800153B true ZA200800153B (en) | 2009-03-25 |
Family
ID=37398540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200800153A ZA200800153B (en) | 2005-06-08 | 2008-01-07 | Inhibitors of soluble adenylate cyclase |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1888058B1 (de) |
| JP (1) | JP2008542422A (de) |
| KR (1) | KR20080016617A (de) |
| CN (1) | CN101193631A (de) |
| AR (1) | AR054378A1 (de) |
| AT (1) | ATE431736T1 (de) |
| AU (1) | AU2006256857A1 (de) |
| BR (1) | BRPI0610934A2 (de) |
| CA (1) | CA2606692A1 (de) |
| CR (1) | CR9578A (de) |
| DE (2) | DE102005027274A1 (de) |
| DO (1) | DOP2006000130A (de) |
| EA (1) | EA200702590A1 (de) |
| EC (1) | ECSP078024A (de) |
| GT (1) | GT200600244A (de) |
| IL (1) | IL186914A0 (de) |
| MX (1) | MX2007015493A (de) |
| NO (1) | NO20080104L (de) |
| PE (1) | PE20061488A1 (de) |
| TW (1) | TW200716090A (de) |
| UY (1) | UY29583A1 (de) |
| WO (1) | WO2006131398A2 (de) |
| ZA (1) | ZA200800153B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006014319B4 (de) * | 2006-03-23 | 2009-01-08 | Bayer Schering Pharma Aktiengesellschaft | Inhibitoren der löslichen Adenylatzyklase |
| EP2036906A1 (de) * | 2007-09-05 | 2009-03-18 | Bayer Schering Pharma Aktiengesellschaft | Azaindole als Inhibitoren der löslichen Adenylatzyklase |
| CA3240990A1 (en) | 2021-12-01 | 2023-06-08 | Pfizer Inc. | 3-phenyl-1-benzothiophene-2-carboxylic acid derivatives as branched-chain alpha keto acid dehydrogenase kinase inhibitors for the treatment of diabetes, kidney diseases, nash and heart failure |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635776B1 (fr) * | 1988-09-01 | 1993-06-11 | Rhone Poulenc Agrochimie | Derives amides, procede pour leur fabrication et compositions fongicides les contenant |
| WO2002020745A1 (en) * | 2000-09-05 | 2002-03-14 | University Of Virginia Patent Foundation | Human soluble testicular adenylyl cyclase |
| PL367680A1 (en) * | 2001-06-28 | 2005-03-07 | Pfizer Products Inc. | Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| CN101851173A (zh) * | 2001-09-14 | 2010-10-06 | 梅特希尔基因公司 | 组蛋白脱乙酰化酶抑制剂 |
| UA79504C2 (en) * | 2002-11-07 | 2007-06-25 | Organon Nv | Indols for treating diseases associated with androgen receptors |
| WO2005013996A2 (en) * | 2003-08-07 | 2005-02-17 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents |
| CA2542096A1 (en) * | 2003-10-09 | 2005-04-21 | Aton Pharma, Inc. | Thiophene and benzothiophene hydroxamic acid derivatives |
| WO2005070419A1 (en) * | 2004-01-21 | 2005-08-04 | Cornell Research Foundation, Inc. | Chemical inhibitors of soluble adenylyl cyclase (sac) |
| CA2559733C (en) * | 2004-03-26 | 2014-05-13 | Methylgene Inc. | Inhibitors of histone deacetylase |
| DE102004047272A1 (de) * | 2004-09-24 | 2006-04-06 | Schering Ag | Inhibitoren der löslichen Adenylatzyklase |
-
2005
- 2005-06-08 DE DE102005027274A patent/DE102005027274A1/de not_active Withdrawn
-
2006
- 2006-06-07 PE PE2006000622A patent/PE20061488A1/es not_active Application Discontinuation
- 2006-06-07 DE DE602006006908T patent/DE602006006908D1/de not_active Expired - Fee Related
- 2006-06-07 EP EP06762012A patent/EP1888058B1/de not_active Not-in-force
- 2006-06-07 CN CNA2006800201485A patent/CN101193631A/zh active Pending
- 2006-06-07 JP JP2008515154A patent/JP2008542422A/ja active Pending
- 2006-06-07 UY UY29583A patent/UY29583A1/es not_active Application Discontinuation
- 2006-06-07 KR KR1020077028637A patent/KR20080016617A/ko not_active Withdrawn
- 2006-06-07 BR BRPI0610934-9A patent/BRPI0610934A2/pt not_active IP Right Cessation
- 2006-06-07 MX MX2007015493A patent/MX2007015493A/es not_active Application Discontinuation
- 2006-06-07 WO PCT/EP2006/005608 patent/WO2006131398A2/en not_active Ceased
- 2006-06-07 AR ARP060102365A patent/AR054378A1/es unknown
- 2006-06-07 AU AU2006256857A patent/AU2006256857A1/en not_active Abandoned
- 2006-06-07 GT GT200600244A patent/GT200600244A/es unknown
- 2006-06-07 AT AT06762012T patent/ATE431736T1/de not_active IP Right Cessation
- 2006-06-07 CA CA002606692A patent/CA2606692A1/en not_active Abandoned
- 2006-06-07 EA EA200702590A patent/EA200702590A1/ru unknown
- 2006-06-08 DO DO2006000130A patent/DOP2006000130A/es unknown
- 2006-06-08 TW TW095120397A patent/TW200716090A/zh unknown
-
2007
- 2007-10-25 IL IL186914A patent/IL186914A0/en unknown
- 2007-12-07 CR CR9578A patent/CR9578A/es not_active Application Discontinuation
- 2007-12-17 EC EC2007008024A patent/ECSP078024A/es unknown
-
2008
- 2008-01-07 NO NO20080104A patent/NO20080104L/no not_active Application Discontinuation
- 2008-01-07 ZA ZA200800153A patent/ZA200800153B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101193631A (zh) | 2008-06-04 |
| PE20061488A1 (es) | 2007-02-03 |
| JP2008542422A (ja) | 2008-11-27 |
| EP1888058A2 (de) | 2008-02-20 |
| WO2006131398A2 (en) | 2006-12-14 |
| TW200716090A (en) | 2007-05-01 |
| AR054378A1 (es) | 2007-06-20 |
| DOP2006000130A (es) | 2006-11-30 |
| ATE431736T1 (de) | 2009-06-15 |
| DE102005027274A1 (de) | 2006-12-14 |
| WO2006131398A3 (en) | 2007-04-19 |
| DE602006006908D1 (de) | 2009-07-02 |
| EA200702590A1 (ru) | 2008-06-30 |
| NO20080104L (no) | 2008-03-03 |
| UY29583A1 (es) | 2007-01-31 |
| IL186914A0 (en) | 2008-02-09 |
| KR20080016617A (ko) | 2008-02-21 |
| CR9578A (es) | 2008-03-06 |
| CA2606692A1 (en) | 2006-12-14 |
| ECSP078024A (es) | 2008-01-23 |
| AU2006256857A1 (en) | 2006-12-14 |
| BRPI0610934A2 (pt) | 2010-08-03 |
| EP1888058B1 (de) | 2009-05-20 |
| GT200600244A (es) | 2007-01-23 |
| MX2007015493A (es) | 2008-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
| ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
| PT2094263E (pt) | Derivados da 2-adamantil-butiramida como inibidores seletivos da 11-beta-hsd1 | |
| IL192580A0 (en) | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | |
| IL222698A0 (en) | Benzazole derivatives, compositions, and methods of use as b- secretase inhibitors | |
| IL198247A0 (en) | Indazole derivatives useful as l-cpt1 inhibitors | |
| IL194755A0 (en) | Pyrimidine derivatives as pi3k inhibitors | |
| IL197090A (en) | A method for the identification of inhibitors of glutaminyl cyclase variants | |
| IL184674A0 (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| ZA200806148B (en) | 2-adamantylurea derivatives as selective 11ß-HSD1 inhibitors | |
| EP2046333A4 (de) | Thiazolidindionderivate als p13-kinase-inhibitoren | |
| IL189048A (en) | Uranium derivatives as 3-gsk inhibitors | |
| IL198640A0 (en) | Hydantoin derivatives used as mmp inhibitors | |
| PL2078001T3 (pl) | Pochodne diazepano-acetamidowe jako selektywne inhibitory 11-hsd1 | |
| IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
| IL194575A0 (en) | Thiazolidinedione derivatives as pi3 kinase inhibitors | |
| ZA200703307B (en) | Indol derivatives as inhibitors of soluble adenylyl cyclase | |
| IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
| IL193981A0 (en) | Novel heterocyclic nf-kb inhibitors | |
| ZA200800153B (en) | Inhibitors of soluble adenylate cyclase | |
| IL188584A0 (en) | Use of soluble guanylate cyclase actiators for treating reperfusion damage | |
| DOP2007000058A (es) | Inhibidores de la adenilato ciclasa soluble | |
| GB0622246D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0623958D0 (en) | Novel inhibitors of glutaminyl cyclase | |
| GB0622245D0 (en) | Novel inhibitors of glutaminyl cyclase |